Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Acting on Autonomic Ganglia: Blockers01:28

Drugs Acting on Autonomic Ganglia: Blockers

Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reliability of polymerase chain reaction in diagnosis of mycobacterial infection.

Chest·1997
Same author

Drug testing in sport: Bayes theorem meets advanced technology.

JAMA·1996
Same author

Get real, Dr. Stobo.

Chest·1996
Same author

Tuberculous empyema presenting after oleothorax.

Respiratory medicine·1995
Same author

Bayes theorem. Diagnostic testing for tuberculosis in children.

Chest·1994
Same author

Can universal precautions spread disease?

Archives of internal medicine·1994

Related Experiment Video

Updated: Jul 24, 2026

Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy
08:50

Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy

Published on: June 25, 2013

Get real, Dr. Block

R Carlen

    Chest
    |December 1, 1996
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    SpOT the Correct Tissue Every Time in Multi-tissue Blocks
    06:53

    SpOT the Correct Tissue Every Time in Multi-tissue Blocks

    Published on: May 31, 2015

    Setup for the Quantitative Assessment of Motion and Muscle Activity During a Virtual Modified Box and Block Test
    04:06

    Setup for the Quantitative Assessment of Motion and Muscle Activity During a Virtual Modified Box and Block Test

    Published on: January 12, 2024

    Related Experiment Videos

    Last Updated: Jul 24, 2026

    Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy
    08:50

    Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy

    Published on: June 25, 2013

    SpOT the Correct Tissue Every Time in Multi-tissue Blocks
    06:53

    SpOT the Correct Tissue Every Time in Multi-tissue Blocks

    Published on: May 31, 2015

    Setup for the Quantitative Assessment of Motion and Muscle Activity During a Virtual Modified Box and Block Test
    04:06

    Setup for the Quantitative Assessment of Motion and Muscle Activity During a Virtual Modified Box and Block Test

    Published on: January 12, 2024